MarketScreener Editorial Features Myriad Genetics, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 10:35:37 2025-05-21 am EDT			5-day change	1st Jan Change
4.290 ^USD	-3.60%		+8.27%	-67.54%

07:13am	Scotiabank Downgrades Myriad Genetics to Sector Perform From Sector Outperform, Adjusts Price Target to $6 From $20	MT
May. 19	Morgan Stanley Cuts Price Target on Myriad Genetics to $7 From $16, Maintains Equalweight Rating	MT

No results for this search